Differentiated thyroid cancer and selenium supplements for protection of salivary glands from 131I treatment

被引：0
|
作者：
Mazokopakis, Elias E. [1 ]
机构：
[1] Naval Hosp Crete, Dept Internal Med, Khania 73200, Crete, Greece
来源：
HELLENIC JOURNAL OF NUCLEAR MEDICINE | 2018年 / 21卷 / 01期
关键词：
HASHIMOTOS-THYROIDITIS; MANAGEMENT;
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：83 / 84
页数：2
相关论文
共 50 条
  • [31] Parameters Influencing Curative Effect of 131I Therapy on Pediatric Differentiated Thyroid Carcinoma: A Retrospective Study
    Xu, Lu
    Liu, Qiong
    Liu, Ying
    Pang, Hua
    MEDICAL SCIENCE MONITOR, 2016, 22 : 3079 - 3085
  • [32] The value of I-131 SPECT in the detection of recurrent differentiated thyroid cancer
    Geerlings, Jackelien A. C.
    van Zuijlen, Anke
    Lohmann, Ellen M.
    Smit, Jan W. A.
    Stokkel, Marcel P. M.
    NUCLEAR MEDICINE COMMUNICATIONS, 2010, 31 (05) : 417 - 422
  • [33] 99mTc-pertechnetate-avid metastases from differentiated thyroid cancer are prone to benefit from 131I therapy A prospective observational studyprospective observational study
    Liu, Min
    Chai, Li
    Luo, Qiong
    Ruan, Maomei
    Cheng, Lingxiao
    Lv, Zhongwei
    Chen, Libo
    MEDICINE, 2017, 96 (33)
  • [34] Radiation Protection Considerations for Cancer Patients with End-stage Renal Disease Receiving 131I Treatment
    Louis, Matthew
    Mate-Kole, Emmanuel M.
    Aziz, Landon
    Dewji, Shaheen A.
    HEALTH PHYSICS, 2024, 126 (01): : 1 - 17
  • [35] Optimizing the indication of initial radioiodine oncolytic treatment for metastatic differentiated thyroid cancer by diagnostic 131 I scan
    He, Z.
    Sa, R.
    Zhang, K.
    Wang, J.
    Qiu, X.
    Chen, L.
    CLINICAL RADIOLOGY, 2024, 79 (07) : e949 - e956
  • [36] Ruling Out 131I Ablation in Low-Risk Differentiated Thyroid Carcinoma Basing on Thyroglobulin Measurement
    Giovanella, Luca
    Verburg, Frederik A.
    THYROID, 2011, 21 (07) : 809 - 810
  • [37] The number of 131I therapy courses needed to achieve complete remission is an indicator of prognosis in patients with differentiated thyroid carcinoma
    Thies, Elena-Daphne
    Tanase, Karina
    Maeder, Uwe
    Luster, Markus
    Buck, Andreas K.
    Haenscheid, Heribert
    Reiners, Christoph
    Verburg, Frederik A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 (12) : 2281 - 2290
  • [38] Comparison of 131I whole-body imaging, 131I SPECT/CT, and 18F-FDG PET/CT in the detection of metastatic thyroid cancer
    Oh, Jong-Ryool
    Byun, Byung-Hyun
    Hong, Sun-Pyo
    Chong, Ari
    Kim, Jahae
    Yoo, Su-Woong
    Kang, Sae-Ryung
    Kim, Dong-Yeon
    Song, Ho-Chun
    Bom, Hee-Seung
    Min, Jung-Joon
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 (08) : 1459 - 1468
  • [39] 131I SPECT/CT in the Follow-up of Differentiated Thyroid Carcinoma: Incremental Value Versus Planar Imaging
    Spanu, Angela
    Solinas, Maria E.
    Chessa, Francesca
    Sanna, Daniela
    Nuvoli, Susanna
    Madeddu, Giuseppe
    JOURNAL OF NUCLEAR MEDICINE, 2009, 50 (02) : 184 - 190
  • [40] Thyroglobulin levels and thyroglobulin/thyrotropin ratio could predict the success of the ablative/therapeutic 131I in the differentiated thyroid cancers
    Carvalho Trevizam, Paula Grasiele
    Tagliarini, Jose Vicente
    Castilho, Emanuel Celice
    Marques, Mariangela de Alencar
    Kiy, Yoshio
    Ferreira da Silva Mazeto, Glaucia Maria
    ENDOCRINE RESEARCH, 2017, 42 (01) : 42 - 48
12345